| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.17 | 0.002 |